Rx Drug Assistance Programs from Pharmaceutical Companies - 0 views
-
avivajazz jazzaviva on 14 Oct 09Amgen to Zeneca!
Group items tagged
MEGA: Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese - 0 views
-
Rader also believes that the MEGA trial raises important questions about just how widespread the use of statin therapy should be in primary prevention...reignite discussion on over-the-counter low-dose statins.
Wiley InterScience :: Cardiovascular Drug Reviews - 0 views
-
Pitavastatin: Efficacy and Safety Profiles of A Novel Synthetic HMG-CoA Reductase Inhibitor
A New Diabetic Drug? HUM-MOLGEN news - 0 views
-
Takashi Kadowaki and colleagues at the University of Tokyo administered adiponectin to obese mice fed a high fat diet & to mice w/reduced levels of body fat, improving insulin resistance & lowering blood glucose levels in both sets of mice.
OrbusNeich "Genous" Bioengineered R Stent is Safe Alternative to Drug-Eluting Stents - 0 views
-
Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents (Randomized TRIAS HR Pilot Study)
Epilepsy Drug (Gabapentin) May Help Alcoholics Recover From Dependence - 0 views
Cardiovascular Drug Discoveries 2008: What's in the Pipeline - 0 views
-
Generx (alferminogene tadenovec, Ad5FGF-4) from Cardium Therapeutics, which is in Phase III for myocardial ischaemia & angina. Darapladib from GSK inhibits lipoprotein-associated phospholipase A2 (Lp-PLA2).
Thrombosis and Drug-Eluting Stents: An Objective Appraisal - 0 views
-
Thrombosis and Drug-Eluting Stents: An Objective Appraisal
COURAGE Quality-of-Life Analysis: Slim Early Gains With PCI Soon Disappear. (QoL) anal... - 0 views
-
Percutaneous coronary intervention (PCI) can often be deferred in patients with stable coronary artery disease (CAD) and significant coronary lesions without adding risk while optimal medical therapy (OMT) is given a chance to work, and it can be consider
Bioabsorbable Drug Eluting Stent Clinical Trials ::::...> Abbott Vascular Press Kit - 0 views
Abbott Laboratories: Bioabsorbable Drug-Eluting Coronary Stent: March 24, 2007 - 0 views
-
Abbott Announces Positive Six-Month Results from the World's First Clinical Trial of A Fully Bioabsorbable Drug-Eluting Coronary Stent\nAbbott's Bioabsorbable Stent Technology Holds Promise as Future-Generation Treatment Option for Physicians Treating Pati
ATryn New Drug Application - 0 views
-
ATryn (antithrombin alfa) Treatment for Antithrombin III Deficiency - BLA Submitted for ATryn\nGTC Biotherapeutics Completes BLA Submission For ATryn
1 - 20 of 20
Showing 20▼ items per page